Insulin resistance and bone strength: findings from the study of midlife in the United States
- PMID: 23983216
- PMCID: PMC3935990
- DOI: 10.1002/jbmr.2083
Insulin resistance and bone strength: findings from the study of midlife in the United States
Abstract
Although several studies have noted increased fracture risk in individuals with type 2 diabetes mellitus (T2DM), the pathophysiologic mechanisms underlying this association are not known. We hypothesize that insulin resistance (the key pathology in T2DM) negatively influences bone remodeling and leads to reduced bone strength. Data for this study came from 717 participants in the Biomarker Project of the Midlife in the United States Study (MIDUS II). The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated from fasting morning blood glucose and insulin levels. Projected 2D (areal) bone mineral density (BMD) was measured in the lumbar spine and left hip using dual-energy X-ray absorptiometry (DXA). Femoral neck axis length and width were measured from the hip DXA scans, and combined with BMD and body weight and height to create composite indices of femoral neck strength relative to load in three different failure modes: compression, bending, and impact. We used multiple linear regressions to examine the relationship between HOMA-IR and bone strength, adjusted for age, gender, race/ethnicity, menopausal transition stage (in women), and study site. Greater HOMA-IR was associated with lower values of all three composite indices of femoral neck strength relative to load, but was not associated with BMD in the femoral neck. Every doubling of HOMA-IR was associated with a 0.34 to 0.40 SD decrement in the strength indices (p<0.001). On their own, higher levels of fasting insulin (but not of glucose) were independently associated with lower bone strength. Our study confirms that greater insulin resistance is related to lower femoral neck strength relative to load. Further, we note that hyperinsulinemia, rather than hyperglycemia, underlies this relationship. Although cross-sectional associations do not prove causality, our findings do suggest that insulin resistance and in particular, hyperinsulinemia, may negatively affect bone strength relative to load.
Keywords: BONE STRENGTH; INSULIN RESISTANCE.
© 2014 American Society for Bone and Mineral Research.
References
-
- Becker DJ, Kilgore ML, Morrisey MA. The societal burden of osteoporosis. Curr Rheumatol Rep. 2010;12(3):186–191. - PubMed
-
- Barcelo A, Gregg EW, Gerzoff RB, Wong R, Perez Flores E, Ramirez-Zea M, Cafiero E, Altamirano L, Ascencio Rivera M, de Cosio G, de Maza MD, del Aguila R, Emanuel E, Gil E, Gough E, Jenkins V, Orellana P, Palma R, Palomo R, Pastora M, Pena R, Pineda E, Rodriguez B, Tacsan L, Thompson L, Villagra L. Prevalence of diabetes and intermediate hyperglycemia among adults from the first multinational study of noncommunicable diseases in six Central American countries: the Central America Diabetes Initiative (CAMDI) Diabetes Care. 2012;35(4):738–740. - PMC - PubMed
-
- Tan DA. Changing disease trends in the Asia-Pacific. Climacteric. 2011;14(5):529–534. - PubMed
-
- van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(Suppl 1):S3–8. - PubMed
Publication types
MeSH terms
Grants and funding
- P01‐AG020166/AG/NIA NIH HHS/United States
- UL1 TR000427/TR/NCATS NIH HHS/United States
- M01 RR000865/RR/NCRR NIH HHS/United States
- R01 AG032271/AG/NIA NIH HHS/United States
- UL1 RR025011/RR/NCRR NIH HHS/United States
- P30 AG028748/AG/NIA NIH HHS/United States
- 1UL1RR025011/RR/NCRR NIH HHS/United States
- R01 AG033067/AG/NIA NIH HHS/United States
- 1R01AG033067/AG/NIA NIH HHS/United States
- M01‐RR000865/RR/NCRR NIH HHS/United States
- RR023942/RR/NCRR NIH HHS/United States
- M01 RR023942/RR/NCRR NIH HHS/United States
- P01 AG020166/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
